Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB
about
UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditionsMolecular mechanisms of chemoresistance in gastric cancerEndogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatinQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsEndoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cellsHypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1AlphaRole of notch signaling in the maintenance of human mesenchymal stem cells under hypoxic conditions.ER stress in retinal degeneration in S334ter Rho rats.Glyoxalase-I is a novel prognosis factor associated with gastric cancer progressionTranscriptional shift identifies a set of genes driving breast cancer chemoresistanceThe role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.Effects of hypoxia on human cancer cell line chemosensitivity.Reciprocal influence of the p53 and the hypoxic pathwaysSirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayStrong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal CancerEpithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer.Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal CancerAnnexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A.Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transitionMicroRNAs as putative mediators of treatment response in prostate cancer.The growing complexity of HIF-1α's role in tumorigenesis: DNA repair and beyond.Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer.Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.NF-κB Signaling in Gastric Cancer.Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1α shRNAs.Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.The Critical Impact of HIF-1a on Gastric Cancer Biology.Effect of carbon dioxide pneumoperitoneum on human renal cell carcinoma proliferation and metastasis in an orthotropic xenograft nude mouse model.STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.
P2860
Q24304069-6935928A-29CA-4446-9191-8BDF0C857693Q28069259-66376E79-ABD0-44A3-91FD-1A32DA32CA18Q28392262-DE437E19-5805-47E8-A2AD-4FAEAFA0BEACQ28478299-63BEF3C0-AF0B-4397-8176-70F34478B43CQ28487624-1C377243-B8FD-47E3-9521-7CF4A5ABBCD3Q28533909-912A4086-34C3-4EEB-AAA6-450B89EBBD11Q34138039-3DB7257F-278B-4EF4-AB34-74D544378749Q34202842-4582868D-A263-42FA-934B-B2E6FBF599BFQ34222449-E9A00D5D-EAD8-47D9-87AF-AE8AE3236D2FQ34552025-C9C56A9B-D091-408C-9CFD-793DEBD6FA0BQ34559250-AADCCFB2-D744-4F57-BF1C-210CE1802BE6Q34799788-9BC1ACA6-47A2-4882-879E-9FD3E35AD83AQ35065006-749BCFB3-98F2-460A-BED2-7F9007659D9EQ35100923-C8AF0D10-75EF-489B-855F-09A698AC8320Q35604870-1772045F-C4F7-4308-AF87-FD82C9E91FEDQ35752267-732628FA-DBBB-4C6B-BBA5-5D6EC66E002FQ35892646-DBD7A117-554C-4A94-A2A2-F603944DDAC2Q35944520-D145DD3A-E73B-4EA2-897A-4150616BDC79Q35998461-B5D7F36B-1F62-4DB4-951C-7697BDCB835AQ36220497-F5928329-BF12-4429-9ACE-E24F1E600DB3Q36531433-64634A94-9090-4AFC-8E1C-EAF2E2835789Q36762304-19BF808B-E008-4FBF-A74E-88B46D835950Q36916313-4613DDF9-24B2-4588-93BD-903B1DCAB371Q37464190-D5738BA6-A211-41D1-BB6C-E5D2B46D709EQ38011943-DDCFE0E9-44FF-441F-B9A6-C7382A1520C7Q38060522-90D57949-BA8D-4901-B534-17190EE25C4AQ38161730-EAE68362-61B9-4A16-8483-5BEA31A3274BQ38819410-E207F89D-5F48-4769-BD9E-AC2411DDA2F8Q38832570-2883E5B9-5144-4C23-9D54-3657D129DA69Q39009310-063675BE-4D4D-4DE1-9336-A0BDF2700E56Q39048636-1BBD3BFE-B107-4136-8D83-95EB563D8387Q39099604-5CF8DEE0-2EFE-435C-ADEC-215C7D6BB1A6Q39144797-4A218D0A-E8C9-4DC8-910F-40CA27B50650Q39204794-4900EC0B-9572-459C-B0D1-79EA9311AA48Q39320799-B0B3497F-563E-4FFC-8538-A652BF51D885Q39367534-EE5541BE-F925-4779-919B-9474650133FFQ41779542-8C6ACAC5-FC31-48E5-9C86-97E1F97FB607Q42000979-408AD47A-6440-4389-BCCB-F77E944171A6Q43499055-AC09C349-8EEE-489C-9756-BCE70CCA9FA1Q47218543-33BF1740-8D18-42C5-818E-560FCDF8A20A
P2860
Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@ast
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@en
type
label
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@ast
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@en
prefLabel
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@ast
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@en
P2093
P2860
P50
P1433
P1476
Hypoxia-inducible factor 1alph ...... odulation of p53 and NF-kappaB
@en
P2093
Anja Haugstetter
Christof Dame
Katharina Detjen
Nadine Rohwer
P2860
P304
P356
10.1371/JOURNAL.PONE.0012038
P407
P577
2010-08-10T00:00:00Z